[HTML][HTML] Strengths and limitations of large databases in lung cancer radiation oncology research

V Jairam, HS Park - Translational lung cancer research, 2019 - ncbi.nlm.nih.gov
There has been a substantial rise in the utilization of large databases in radiation oncology
research. The advantages of these datasets include a large sample size and inclusion of a …

ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer

M Guckenberger, N Andratschke, K Dieckmann… - Radiotherapy and …, 2017 - Elsevier
Background Stereotactic body radiotherapy (SBRT) has become the standard of care for
medically inoperable patients with peripherally located, early stage non-small cell lung …

Pulmonary imaging after stereotactic radiotherapy—does RECIST still apply?

SA Mattonen, AD Ward, DA Palma - The British journal of …, 2016 - academic.oup.com
The use of stereotactic ablative radiotherapy (SABR) for the treatment of primary lung cancer
and metastatic disease is rapidly increasing. However, the presence of benign fibrotic …

[HTML][HTML] Biologically effective dose in stereotactic body radiotherapy and survival for patients with early-stage NSCLC

AC Moreno, B Fellman, BP Hobbs, Z Liao… - Journal of Thoracic …, 2020 - Elsevier
Introduction Stereotactic body radiotherapy (SBRT) results in excellent local control of stage
I NSCLC. Radiobiology models predict greater tumor response when higher biologically …

Correlating dose variables with local tumor control in stereotactic body radiation therapy for early-stage non-small cell lung cancer: a modeling study on 1500 …

RJ Klement, JJ Sonke, M Allgäuer… - International Journal of …, 2020 - Elsevier
Background Large variation regarding prescription and dose inhomogeneity exists in
stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer. The …

Practice patterns and outcomes in elderly stage I non–small-cell lung cancer: a 2004 to 2012 SEER analysis

SM Dalwadi, SS Szeja, EH Bernicker, EB Butler… - Clinical lung cancer, 2018 - Elsevier
Background We reviewed the population-based treatment patterns and outcomes for elderly
patients with stage I non–small-cell lung cancer (NSCLC) treated from 2004 to 2012 …

[HTML][HTML] Trends and variations in treatment of stage I–III non-small cell lung cancer from 2008 to 2018: A nationwide population-based study from the Netherlands

J Evers, K de Jaeger, LEL Hendriks, M van der Sangen… - Lung Cancer, 2021 - Elsevier
Abstract Introduction This Dutch population-based study describes nationwide treatment
patterns and its variations for stage I-III non-small cell lung cancer (NSCLC). Materials and …

Survival of primary stereotactic body radiation therapy compared with surgery for operable stage I/II non-small cell lung cancer

R Khorfan, TJ Kruser, JM Coughlin, A Bharat… - The Annals of thoracic …, 2020 - Elsevier
Background Stereotactic body radiation therapy (SBRT) is an accepted primary treatment
option for inoperable early-stage non-small cell lung cancer (NSCLC). The role of SBRT in …

[HTML][HTML] Surgical quality of wedge resection affects overall survival in patients with early stage non–small cell lung cancer

GS Ajmani, CH Wang, KW Kim, JA Howington… - The Journal of Thoracic …, 2018 - Elsevier
Objectives Very few studies have examined the quality of wedge resection in patients with
non–small cell lung cancer. Using the National Cancer Database, we evaluated whether the …

High single doses of radiation may induce elevated levels of hypoxia in early-stage non-small cell lung cancer tumors

OJ Kelada, RH Decker, SK Nath, KL Johung… - International Journal of …, 2018 - Elsevier
Purpose Tumor hypoxia correlates with treatment failure in patients undergoing
conventional radiation therapy. However, no published studies have investigated tumor …